Two recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

There are a total of 93 products in Phase I-III development for PD treatment. The Parkinson’s disease (PD) therapeutic ...

Parkinson’s UK’s Halifax branch is hosting a fundraising event this weekend and is inviting residents to come along and enjoy ...

Dozens of neurologists are calling on the Australian chemicals regulator to ban paraquat, a toxic herbicide that has been linked to the development of Parkinson's disease.

A cotton industry advocate says dryland crops are at risk if the regulator lowers the usage rate of a chemical that has been ...

As a reminder, Acadia Pharmaceuticals has two primary products on the market. The first is Nuplazid, which was approved in ...

Creators, who were once dependent on ad revenue, now have multiple streams of income. But their audiences expect more from ...

“Parkinson’s disease doesn’t wait for you ... partnerships so we may receive compensation for some links to products and services.

Amneal Pharmaceuticals Q3 sales rose 13% to $702.47 million, beating estimates. EPS hit $0.16, above consensus, driven by ...

"People living with advanced Parkinson's disease experience daily challenges ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries ...